Healthcare provider profile · identity verified

Quentin Eugene Stenger, PA-C

Physician Assistant · EVANSDALE, IA · NPI 1245547983

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	458	121
Lisinopril	Lisinopril	198	57
Montelukast Sodium	Montelukast Sodium	192	46
Levothyroxine Sodium	Levothyroxine Sodium	188	52
Furosemide	Furosemide	184	46
Pantoprazole Sodium	Pantoprazole Sodium	179	57
Amlodipine Besylate	Amlodipine Besylate	173	47
Omeprazole	Omeprazole	168	44
Losartan Potassium	Losartan Potassium	164	43
Metoprolol Succinate	Metoprolol Succinate	161	38
Duloxetine Hcl	Duloxetine Hcl	148	22
Gabapentin	Gabapentin	135	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	124	30
Albuterol Sulfate Hfa	Albuterol Sulfate	123	46
Mounjaro	Tirzepatide	121	23
Ozempic	Semaglutide	120	17
Jardiance	Empagliflozin	109	24
Metformin Hcl	Metformin Hcl	101	31
Potassium Chloride	Potassium Chloride	90	23
Tamsulosin Hcl	Tamsulosin Hcl	88	26
Simvastatin	Simvastatin	87	26
Trazodone Hcl	Trazodone Hcl	85	25
Allopurinol	Allopurinol	82	24
Eliquis	Apixaban	76	18
Pregabalin	Pregabalin	76	18
Warfarin Sodium	Warfarin Sodium	74	suppressed
Meloxicam	Meloxicam	69	30
Fluticasone Propionate	Fluticasone Propionate	68	21
Hydrochlorothiazide	Hydrochlorothiazide	66	21
Diclofenac Sodium	Diclofenac Sodium	64	20
Celecoxib	Celecoxib	63	suppressed
Sertraline Hcl	Sertraline Hcl	62	18
Trulicity	Dulaglutide	61	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	60	14
Rosuvastatin Calcium	Rosuvastatin Calcium	60	17
Carvedilol	Carvedilol	52	13
Zolpidem Tartrate	Zolpidem Tartrate	52	11
Escitalopram Oxalate	Escitalopram Oxalate	51	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	18
Lovastatin	Lovastatin	48	13
Nabumetone	Nabumetone	48	22
Azithromycin	Azithromycin	47	40
Prednisone	Prednisone	47	40
Doxepin Hcl	Doxepin Hcl	46	11
Metoprolol Tartrate	Metoprolol Tartrate	45	14
Spironolactone	Spironolactone	45	suppressed
Lorazepam	Lorazepam	44	20
Ezetimibe	Ezetimibe	41	12
Famotidine	Famotidine	40	14
Tramadol Hcl	Tramadol Hcl	40	21
Cephalexin	Cephalexin	39	33
Clopidogrel	Clopidogrel Bisulfate	39	16
Ropinirole Hcl	Ropinirole Hcl	38	11
Tizanidine Hcl	Tizanidine Hcl	38	12
Fluconazole	Fluconazole	34	suppressed
Ventolin Hfa	Albuterol Sulfate	33	suppressed
Alprazolam	Alprazolam	32	12
Doxycycline Hyclate	Doxycycline Hyclate	31	20
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Olanzapine	Olanzapine	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Metformin Hcl Er	Metformin Hcl	28	13
Baclofen	Baclofen	27	suppressed
Clonazepam	Clonazepam	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Terbinafine Hcl	Terbinafine Hcl	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Mupirocin	Mupirocin	24	16
Atenolol	Atenolol	23	suppressed
Finasteride	Finasteride	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Jantoven	Warfarin Sodium	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Fosinopril Sodium	Fosinopril Sodium	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Indomethacin	Indomethacin	18	suppressed
Ketoconazole	Ketoconazole	18	11
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Glimepiride	Glimepiride	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	16	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Bumetanide	Bumetanide	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Ibuprofen	Ibuprofen	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Naltrexone Hcl	Naltrexone Hcl	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Temazepam	Temazepam	13	suppressed
Xtampza Er	Oxycodone Myristate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Rybelsus	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error